scispace - formally typeset
Open AccessJournal ArticleDOI

Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review

TLDR
Improving adherence in schizophrenia may have a considerable positive impact on patients and society by focusing on the identified multitude of factors driving nonadherence, including lack of insight, medication beliefs and substance abuse.
Abstract
Background:Nonadherence to medication is a recognized problem and may be the most challenging aspect of treatment.Methods:We performed a systematic review of factors that influence adherence and the consequences of nonadherence to the patient, healthcare system and society, in patients with schizophrenia. Particular attention was given to the effect of nonadherence on hospitalization rates, as a key driver of increased costs of care. A qualitative systematic literature review was conducted using a broad search strategy using disease and adherence terms. Due to the large number of abstracts identified, article selection was based on studies with larger sample sizes published after 2001. Thirty-seven full papers were included: 15 studies on drivers and 22 on consequences, of which 12 assessed the link between nonadherence and hospitalization.Results:Key drivers of nonadherence included lack of insight, medication beliefs and substance abuse. Key consequences of nonadherence included greater risk of relapse,...

read more

Citations
More filters
Journal ArticleDOI

Comparative effectiveness of long-acting injectable antipsychotics in patients with schizophrenia in Japan

TL;DR: In this article , the effectiveness of different long-acting injectable antipsychotics (LAIs) (aripiprazole, paliperidone, risperidone and fluphenazine/haloperidol) in patients with schizophrenia in Japan was compared.
Journal ArticleDOI

Understanding the medication safety challenges for patients with mental illness in primary care: a scoping review

TL;DR: In this article , the authors defined medication safety challenges using the drug-related problems (DRPs) categorisation and highlighted the need for further research on the causes of preventable medication incidents and targeted interventions to improve medication safety for patients with mental illness in primary care.
Journal ArticleDOI

Long-Acting Injectable Second-Generation Antipsychotics vs Placebo and Their Oral Formulations in Acute Schizophrenia: A Systematic Review and Meta-Analysis of Randomized-Controlled-Trials.

TL;DR: In this paper , the authors conducted a systematic review and meta-analysis of randomized-controlled-trials (RCTs) comparing the second-generation long-acting injectable antipsychotics (SGA-LAIs) olanzapine, risperidone, paliperidone and aripiprazole with placebo or their oral counterparts in acutely ill patients with schizophrenia.
Journal ArticleDOI

Bei Risiken und Nebenwirkungen fragen Sie Ihre… Patientinnen und Patienten

TL;DR: In this paper , an item pool für the Risikowahrnehmung des Absetzens und Einnehmens von Antipsychotika was generated.
Journal ArticleDOI

Psychotropic medicine beliefs, side effects and adherence in schizophrenia: a patient–caregiver dyad perspective

TL;DR: In this article, the authors examined the association among beliefs about psychotropic medications, side effects and medication adherence from a patient-caregiver dyad perspective using an interviewer-administered data collection approach.
References
More filters
Journal ArticleDOI

The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness.

TL;DR: Recommendations for addressing adherence problems to improve patient outcomes are developed, noting that multiple problems may be involved, requiring a combination of interventions.
Journal ArticleDOI

Partial Compliance and Risk of Rehospitalization Among California Medicaid Patients With Schizophrenia

TL;DR: This study showed a direct correlation between estimated partial compliance and hospitalization risk among patients with schizophrenia across a continuum of compliance behavior.
Related Papers (5)

The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness.